IDEAS home Printed from
   My bibliography  Save this article

Assessing the Role of TRIPS Agreement for Inaccessibility and Un-affordability of Essential Medicines in Nigeria


  • Umar Abubakar Dubagari

    () (Department of Public Law and Jurisprudence, Faculty of Law, Usmanu Danfodiyo University, P.M.B. 2346, Sokoto – Nigeria.)


Intellectual property rights (IPRs) protection was not recognised in Nigeria and essential medicines were accessible and affordable to all but reverse is the case with the implementation of TRIPS agreement on IPRs. This resulted in inordinate policy formulation and implementation that exacerbates the public health care despite Nigeria’s endowment with enormous human and natural resources. This paper argues that patents protection hinders access and affordability to essential medicines in Nigeria. It also argues that pharmaceutical companies prevent developing countries from utilising the TRIPS flexibilities to access essential medicines for their citizens. It concludes that access and affordability to essential medicines are additional challenges to Nigeria. The paper is based on the anti-corporate globalisation movement theory. The theory advocates for a world structured by human values other than greed and domination, one less dominated by the culture and values of global capital. The economic, political, and cultural interconnectedness signified by globalisation is irreversible and possibly a good thing, this interconnection, could potentially serve the interests of people and the earth, not just the elites. Although the rich and powerful have shaped globalisation in their interest, the anti-globalisation theory is a counter-movement that seeks to reshape the interconnected world in the interests of people and the planet.

Suggested Citation

  • Umar Abubakar Dubagari, 2015. "Assessing the Role of TRIPS Agreement for Inaccessibility and Un-affordability of Essential Medicines in Nigeria," Journal of Commerce and Trade, Society for Advanced Management Studies, vol. 10(1), pages 7-19, April.
  • Handle: RePEc:jct:journl:v:10:y:2015:i:1:p:7-19

    Download full text from publisher

    File URL:
    Download Restriction: no

    More about this item


    Anti-Globalisation; Pharmaceutical Corporations; Patent; Essential Drugs; Nigeria;

    JEL classification:

    • I14 - Health, Education, and Welfare - - Health - - - Health and Inequality
    • I18 - Health, Education, and Welfare - - Health - - - Government Policy; Regulation; Public Health
    • Z0 - Other Special Topics - - General


    Access and download statistics


    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:jct:journl:v:10:y:2015:i:1:p:7-19. See general information about how to correct material in RePEc.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Dr. Himanshu Agarwal). General contact details of provider: .

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service hosted by the Research Division of the Federal Reserve Bank of St. Louis . RePEc uses bibliographic data supplied by the respective publishers.